explore
The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.
Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.
advertisement
The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
Vertex non
Next article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Medicare proposal to cover medical devices draws a mixed reaction
